BACKGROUND: Subtle, but clinically detectable, neurological abnormalities (SNAs) are associated with impaired physical performance in elderly persons without overt neurological diseases. We investigated whether SNAs were prospectively associated with cognitive and functional status, death, and cerebrovascular events (CVEs) in older community-dwelling individuals. METHODS: In participants without history of stroke, parkinsonism and dementia, or cognitive impairment, a score (N(SNA)) was obtained by summing SNAs detected with a simple neurological examination. Cognitive status and disability were reassessed 4 years later, and deaths and CVEs were documented over 8 years. RESULTS: Of 506 participants free of neurological diseases (mean [SEM] age, 71.9 [0.3] years; 42% were men), 59% had an N(SNA) of 1 or more (mean [SEM], 1.1 [0.06]; range, 0-8). At baseline, the N(SNA) increased with age and with declining cognitive and physical performance, depressive symptoms, and disability, after adjusting for several covariates, but did not increase with falls and urinary incontinence. The N(SNA) prospectively predicted worsening cognitive status and disability, adjusting for demographics and for baseline comorbidity and cognitive and physical performance. The mortality rates were 22.6, 23.3, 23.9, 58.6, and 91.9 per 1000 person-years in participants with an N(SNA) of 0, 1, 2, 3, and 4 or higher, respectively. Compared with an N(SNA) of less than 3, having an N(SNA) of 3 or higher was associated with an increased adjusted risk of death (hazard ratio, 1.77; 95% confidence interval [CI], 1.25-2.74) and of CVE (hazard ratio, 1.94; 95% CI, 1.07-3.54) over 8 years. CONCLUSION: In this sample of older community-dwelling persons without overt neurological diseases, multiple SNAs were associated with cognitive and functional decline and independently predicted mortality and CVEs.
BACKGROUND: Subtle, but clinically detectable, neurological abnormalities (SNAs) are associated with impaired physical performance in elderly persons without overt neurological diseases. We investigated whether SNAs were prospectively associated with cognitive and functional status, death, and cerebrovascular events (CVEs) in older community-dwelling individuals. METHODS: In participants without history of stroke, parkinsonism and dementia, or cognitive impairment, a score (N(SNA)) was obtained by summing SNAs detected with a simple neurological examination. Cognitive status and disability were reassessed 4 years later, and deaths and CVEs were documented over 8 years. RESULTS: Of 506 participants free of neurological diseases (mean [SEM] age, 71.9 [0.3] years; 42% were men), 59% had an N(SNA) of 1 or more (mean [SEM], 1.1 [0.06]; range, 0-8). At baseline, the N(SNA) increased with age and with declining cognitive and physical performance, depressive symptoms, and disability, after adjusting for several covariates, but did not increase with falls and urinary incontinence. The N(SNA) prospectively predicted worsening cognitive status and disability, adjusting for demographics and for baseline comorbidity and cognitive and physical performance. The mortality rates were 22.6, 23.3, 23.9, 58.6, and 91.9 per 1000 person-years in participants with an N(SNA) of 0, 1, 2, 3, and 4 or higher, respectively. Compared with an N(SNA) of less than 3, having an N(SNA) of 3 or higher was associated with an increased adjusted risk of death (hazard ratio, 1.77; 95% confidence interval [CI], 1.25-2.74) and of CVE (hazard ratio, 1.94; 95% CI, 1.07-3.54) over 8 years. CONCLUSION: In this sample of older community-dwelling persons without overt neurological diseases, multiple SNAs were associated with cognitive and functional decline and independently predicted mortality and CVEs.
Authors: Jonathan F Bean; Dan K Kiely; Suzanne G Leveille; Seth Herman; Charlie Huynh; Roger Fielding; Walter Frontera Journal: J Gerontol A Biol Sci Med Sci Date: 2002-11 Impact factor: 6.053
Authors: Domenico Inzitari; Michela Simoni; Giovanni Pracucci; Anna Poggesi; Anna Maria Basile; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Michael Hennerici; Peter Langhorne; John O'Brien; Frederik Barkhof; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Leonardo Pantoni Journal: Arch Intern Med Date: 2007-01-08
Authors: G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman Journal: Can Med Assoc J Date: 1985-04-15 Impact factor: 8.262
Authors: Paul L Enright; Mary Ann McBurnie; Vera Bittner; Russell P Tracy; Robert McNamara; Alice Arnold; Anne B Newman Journal: Chest Date: 2003-02 Impact factor: 9.410
Authors: Luigi Ferrucci; Stefania Bandinelli; Chiara Cavazzini; Fulvio Lauretani; Annamaria Corsi; Benedetta Bartali; Antonio Cherubini; Lenore Launer; Jack M Guralnik Journal: Am J Med Date: 2004-06-15 Impact factor: 4.965
Authors: Anne B Newman; Alice M Arnold; Barbara L Naydeck; Linda P Fried; Gregory L Burke; Paul Enright; John Gottdiener; Calvin Hirsch; Daniel O'Leary; Russell Tracy Journal: Arch Intern Med Date: 2003-10-27
Authors: Sari Stenholm; Michelle Shardell; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2015-03-07 Impact factor: 6.053
Authors: Marco Inzitari; Andrea Metti; Caterina Rosano; Cristina Udina; Laura M Pérez; Gabriela Carrizo; Joe Verghese; Anne B Newman; Stephanie Studenski; Andrea L Rosso Journal: Exp Gerontol Date: 2019-07-06 Impact factor: 4.032
Authors: Jennifer S Brach; Sara J Francois; Jessie M VanSwearingen; Sandra Gilmore; Subashan Perera; Stephanie A Studenski Journal: PM R Date: 2015-10-19 Impact factor: 2.298
Authors: Michael S Avidan; Adam C Searleman; Martha Storandt; Kara Barnett; Andrea Vannucci; Leif Saager; Chengjie Xiong; Elizabeth A Grant; Dagmar Kaiser; John C Morris; Alex S Evers Journal: Anesthesiology Date: 2009-11 Impact factor: 7.892
Authors: Anna Poggesi; Alida Gouw; Wiesje van der Flier; Giovanni Pracucci; Hugues Chabriat; Timo Erkinjuntti; Franz Fazekas; José M Ferro; Christian Blahak; Peter Langhorne; John O'Brien; Reinhold Schmidt; Marieke C Visser; Lars-Olof Wahlund; Gunhild Waldemar; Anders Wallin; Philip Scheltens; Domenico Inzitari; Leonardo Pantoni Journal: J Neurol Date: 2014-04-11 Impact factor: 4.849